Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Enterprise Value (2025 - 2026)

Updated

Drugs Made In America Acquisition (DMII) recorded Enterprise Value of $640.65 million in Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Enterprise Value (2025 - 2026) Analysis & Trends

On a TTM basis, Drugs Made In America Acquisition's Enterprise Value came in at $640.31 million as of Jun 30, 2026; for FY2025, it was $258.45 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn -
3 Blackstone 84.08 Bn 79.01 Bn -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn
5 Kkr 81.05 Bn 47.53 Bn -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 640.65 Mn
Dec 31, 2025 258.45 Mn
API Access

Drugs Made In America Acquisition Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=DMII&period=max&api_key=YOUR_API_KEY